Loading...
Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer
Immune checkpoint blockade (ICB) has a limited effect on colorectal cancer, underlining the requirement of co‐targeting the complementary mechanisms. Here, we identified prostaglandin E2 (PGE(2)) receptor 4 (EP4) as the master regulator of immunosuppressive myeloid cells (IMCs), which are the major...
Na minha lista:
| Udgivet i: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7799360/ https://ncbi.nlm.nih.gov/pubmed/33283987 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.202012798 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|